Trial Profile
Pharmacokinetics and Metabolism of [14C] BMS-986205 in Healthy Male Participants
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2017
Price :
$35
*
At a glance
- Drugs Linrodostat (Primary)
- Indications Cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Bristol-Myers Squibb
- 31 Oct 2017 Status changed from recruiting to completed.
- 14 Aug 2017 New trial record